Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery

Clinical trial NCT00645671 · COMPLETED

Trial details

NCT number: NCT00645671
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Inflammation

Start date: 2008-03-01
Primary completion: 2009-03-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.